CIBC World Market’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-11,340
Closed -$53K 1335
2024
Q2
$53K Buy
+11,340
New +$64K ﹤0.01% 1237
2023
Q1
Sell
-10,565
Closed -$94K 1261
2022
Q4
$94K Sell
10,565
-11,052
-51% -$121K ﹤0.01% 1203
2022
Q3
$265K Sell
21,617
-21,868
-50% -$341K ﹤0.01% 1048
2022
Q2
$514K Buy
43,485
+8,996
+26% +$121K ﹤0.01% 874
2022
Q1
$656K Buy
34,489
+24,698
+252% +$459K ﹤0.01% 857
2021
Q4
$260K Sell
9,791
-5,628
-37% -$194K ﹤0.01% 1172
2021
Q3
$633K Sell
15,419
-2,885
-16% -$158K ﹤0.01% 904
2021
Q2
$1.04M Buy
18,304
+1,446
+9% +$53.4K ﹤0.01% 780
2021
Q1
$708K Buy
+16,858
New +$960K ﹤0.01% 864
2020
Q4
Sell
-7,392
Closed -$207K 1268
2020
Q3
$207K Buy
+7,392
New +$241K ﹤0.01% 1031

Other funds holding EDIT

CIBC World Market's EDIT Position: Q3 2024 in Review

CIBC World Market sold out of Editas Medicine (EDIT) in Q3 2024, closing a stake of 11,340 shares — an estimated $53K sold.

CIBC World Market first reported a position in EDIT in Q3 2020 and held it in 10 quarters. The position peaked at $1.04M in Q2 2021. 229 funds tracked by Wall St. Rank hold EDIT as of Q3 2024.

  • CIBC World Market reported no remaining Editas Medicine position as of Q3 2024 after selling out during the quarter.
  • CIBC World Market sold 11,340 Editas Medicine shares in Q3 2024, an estimated $53K.
  • CIBC World Market first reported a position in Editas Medicine in Q3 2020 and held it in 10 quarters.
  • CIBC World Market's Editas Medicine position peaked at $1.04M in Q2 2021.
  • 229 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2024.

Based on CIBC World Market's 13F filing for Q3 2024, filed 12 Nov 2024.